Topic: Omega Variant

Pfizer CEO Albert Bourla and the CEO of Moderna both indicated that the world is moving toward a scenario of annual COVID-19 re-vaccinations. While Bourla suggested life could return to "normal" within a year, he emphasized that vaccinations would remain a permanent fixture of daily life. The discussion also touches on the naming of future variants, including the "Omega" variant.

NIH Director Francis Collins discusses the potential emergence of an "Omega" variant during an interview with Hugh Hewitt. The hosts speculate that the naming of new variants like Lambda and Omega is part of a strategic effort to maintain public concern and justify ongoing medical interventions.